Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Acta Médica Peruana
versión On-line ISSN 1728-5917
Resumen
ROCCA NACION, Jesús et al. Achieving early metabolic control in adults with type diabetes mellitus in Peru. Acta méd. Peru [online]. 2023, vol.40, n.1, pp.31-39. Epub 09-Mayo-2023. ISSN 1728-5917. http://dx.doi.org/10.35663/amp.2023.401.2554.
Aim:
To estimate the proportion of subjects with type 2 diabetes mellitus (T2DM) who attain therapeutic goal for HbA1C one year after diagnosis (early metabolic control).
Methods:
Retrospective review of medical records of adults cared for at 16 centers in nine Peruvian cities. Patients who received an initial diagnosis of T2DM and had at least one year of follow up were included. Metabolic goals were as defined by ADA 2018 standards.
Results:
457 subjects were included (53,03% female). At diagnosis, mean age was 55,75 years (SD ± 12.92), mean HbA1C was 9,10% (SD ± 2,28). Concomitant hypertension or dyslipidemia were present in 27,13% and 52,40%, respectively. At one year follow up, 57,76% of subjects attained the goal for HbA1C (<7,0%). Achievement of goals for other parameters was 39,66% for LDL-c (<100 mg/dL), 55,56% for HDL-c in men (> 40 mg/dL), 24,31% for HDL-c in women (>50 mg/dL), 48,24% for triglycerides (<150 mg/dL), and 89,23% for blood pressure (<140/90 mmHg).
Conclusions:
In this real-life study of adults with T2DM with one year of follow up, metabolic control for HbA1C (<7%) was attained in 58% of subjects. While the results are compatible with those reported in other studies in the region, there is opportunity to further improve early treatment goal attainment to optimize long-term outcomes.
Palabras clave : Diabetes Mellitus, Type 2; Glycated Hemoglobin; Follow-Up Studies; Peru.